Charles Porter Andrews, M.d., P.a.

4410 Medical Dr Suite 550, San Antonio, Texas
Hours available

Do you work at Charles Porter Andrews, M.d., P.a.?

Claim this listing to manage your clinic's info, help your patients access care, and get free admin automation tools. Or learn more in a demo with our team.

About the Clinic

Dr. Charles P. Andrews is a pulmonologist in San Antonio, Texas, affiliated with Methodist Hospital-San Antonio. He specializes in disorders of the lungs and respiratory system, including critical care medicine and pleural disease.

Patient & Visitor Experience

Best Fit Patients

Patients seeking pulmonology services, including those with critical care needs or pleural disease.

Insurances Accepted

HCSC HMO

Location

Address

4410 Medical Dr Suite 550, San Antonio, Texas, United States

Map loads when you scroll here

Specialties

The following types of medical expertise are offered in Charles Porter Andrews, M.d., P.a.

  • Neurosurgeon
  • Nurse Practitioner
  • Pediatrician
  • Cardiologist
  • Orthopedic Surgeon
  • General Surgeon
  • Respirologist
  • Anesthesiologist
  • Urgent Care
  • Cardiothoracic Surgeon
  • Vascular Surgeon
  • Internist
  • Pediatric Surgeon

Telehealth

Available — Call Dr. Andrews for more information on telehealth services.

Other Information

Additional Phone Numbers

Phone Number210-692-7157
Hospital Affiliations

["Methodist Hospital-San Antonio"]

Research Involvement

Responses to ragweed pollen in a pollen challenge chamber versus seasonal exposure identify allergic rhinoconjunctivitis endotypes Jacobs RL, Harper N, He W, Andrews CP, Rather CG The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis Andrews CP, Ratner PH, Ehler BR, Brooks EG, Pollack BH, Ramirez DA, Jacobs RL A phase I randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, and immunogenicity of a live-attenuated quadrivalent dengue vaccine in flavivirus-naïve and flavivirus-experienced healthy adults. Kevin L Russell, Javier O Morales-Ramirez, Clemente Diaz-Perez, Andrew W Lee, Tyler S Finn, Kara S Cox, Amy Falk Russell, Margaret M Schaller, Jason C Martin, Donna M Hyatt, Sabrina Gozlan-Kelner, Androniki Bili, Beth-Ann G Coller, Richard E Rupp, Charles P Andrews Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma Alisha M. Smith, Robert M. Ramirez, Nathan Harper, Fabio Jimenez, Anne P. Branum, Justin A. Meunier, Lavanya Pandranki, Andrew Carrillo, Caitlyn Winter, Lauryn Winter, Cynthia G. Rather, Daniel A. Ramirez, Charles P. Andrews, Marcos I. Restrepo, Diego J. Maselli, Jacqueline A. Pugh, Robert A. Clark, Grace C. Lee, Alvaro G. Moreira, Muthu Saravanan Manoharan, Jason F. Okulicz, Sunil K. Ahuja Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases Alisha M. Smith, Nathan Harper, Justin A. Meunier, Anne P. Branum, Fabio Jimenez, Lavanya Pandranki, Andrew Carrillo, Charles S. Dela Cruz, Marcos I. Restrepo, Diego J. Maselli, Cynthia G. Rather, Anna H. Heisser, Daniel A. Ramirez, Weijing He, Robert A. Clark, Charles P. Andrews, Scott E. Evans, Jacqueline A. Pugh, Nu Zhang, Grace C. Lee, Alvaro G. Moreira, Leopoldo N. Segal, Robert M. Ramirez, Robert L. Jacobs, Muthu Saravanan Manoharan, Jason F. Okulicz, Sunil K. Ahuja Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older. Ulrike K. Buchwald, Charles P. Andrews, John Ervin, James T. Peterson, Gretchen M. Tamms, David Krupa, Patrick Ajiboye, Lucy Roalfe, Andrea Likos Krick, Tina M. Sterling, Meihua Wang, Jason C. Martin, Jon E. Stek, Melvin A Kohn, Temitope Folaranmi, Chitrananda Abeygunawardana, Jonathan Hartzel, Luwy Musey Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis Charles P. Andrews, Dale Mohar, Yacine Salhi, Sudeesh K. Tantry Clinical standardization of two controlled allergen challenge facilities: The Environmental Exposure Unit and the Biogenics Research Chamber. Anne K. Ellis, Robert L. Jacobs, Mark W. Tenn, Lisa M. Steacy, Daniel E. Adams, Terry J. Walker, Alkis Togias, Daniel A. Ramirez, Cynthia M. Visness, Robert James, Cynthia G. Rather, Charles P. Andrews Frequency of goose and duck down causation of hypersensitivity pneumonitis within an 80-patient cohort Matthew R. Jacobs, Robert M. Ramirez, Robert L. Jacobs, Charles P. Andrews Immune responses to a recombinant glycoprotein E Herpes Zoster vaccine in adults aged 50 and older Cunningham A, Heineman T, Lal H, Godeaux o, Chilibek R, Hwang J, McElhaney J, Vesikari T, Andrews C, et al Safety and Immunogenicity of 15-valent pneumococcal congugate vaccine in pneumococcal vaccine-naive adults 50 years of age and older Ermlich S, Andrews C, Folkreth S, Rupp R, Greenberg D Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine in pneumococcal vaccine-naïve adults ≥50 years of age Susan Ermlich, Steven D. Folkerth, Richard E. Rupp, David Greenberg, Richard D. McFetridge, Jonathan Hartzel, Rocio D. Marchese, Jon E. Stek, Chitrananda Abeygunawardana, Luwy Musey, Charles P. Andrews Six-Month Safety Data of Recombinant Vesicular Stomatitis Virus-Zaire Ebola Virus Envelope Glycoprotein Vaccine in a Phase 3 Double-Blind, Placebo-Controlled Randomized Study in Healthy Adults. Scott A. Halperin, Jose R. Arribas, Richard E. Rupp, Laurence Chu, Jakub K. Simon, Matthew T. Onorato, Kenneth Liu, Jason C. Martin, Frans A. Helmond, Rituparna Das, Charles P. Andrews Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies. Paul H. Ratner, Frank C. Hampel, Bruce G. Martin, Dale Mohar, Denis Bourrelly, Parisa Danaietash, Sara Mangialaio, Jasper Dingemanse, Abdel Hmissi, Jay van Bavel, Charles P. Andrews Preservation of epithelial cell barrier function and muted inflammation in resistance to allergic rhinoconjunctivitis from house dust mite challenge Sunil K. Ahuja, Muthu Saravanan Manoharan, Nathan Harper, Fabio Jimenez, Benjamin D. Hobson, Hernan Martinez, Puraskar Ingale, Ya Guang Liu, Andrew Carrillo, Zheng Lou, Dean L. Kellog, Seema S. Ahuja, Cynthia G. Rather, Robert E. Esch, Daniel A. Ramirez, Robert A. Clark, Kari C. Nadeau, Charles P. Andrews, Robert L. Jacobs, Weijing He Redness response phenotypes of allergic conjunctivitis in an allergen challenge chamber Robert L. Jacobs, Daniel A. Ramirez, Cynthia G. Rather, Daniel C. Jupiter, David G. Shulman, Charles P. Andrews, Fernando Trujillo Cockroach sensitization mitigates allergic rhinoconjunctivitis symptom severity in patients allergic to house dust mites and pollen. Weijing He, Fabio Jimenez, Hernan Martinez, Nathan Harper, Muthu Saravanan Manoharan, Andrew Carrillo, Puraskar Ingale, Ya Guang Liu, Seema S. Ahuja, Robert A. Clark, Cynthia G. Rather, Daniel A. Ramirez, Robert L. Jacobs, Sunil K. Ahuja, Charles P. Andrews Symptom dynamics during repeated serial allergen challenge chamber exposures to house dust mite. Robert L. Jacobs, Charles P. Andrews, Daniel A. Ramirez, Cynthia G. Rather, Nathan Harper, Fabio Jimenez, Hernan Martinez, Muthu Saravanan Manoharan, Andrew Carrillo, Margit B. Gerardi, Robert E. Esch, Weijing He, Sunil K. Ahuja Responsiveness to timothy grass pollen in individuals without known natural exposure in an allergen challenge chamber. Daniel A. Ramirez, Charles P. Andrews, Cynthia G. Rather, Robert L. Jacobs Effect of confounding cofactors on responses to pollens during natural season versus pollen challenge chamber exposure Robert L. Jacobs, Nathan Harper, Weijing He, Cynthia G. Rather, Daniel A. Ramirez, Sunil K. Ahuja, Charles P. Andrews The mountain cedar model in clinical trials of seasonal allergic rhinoconjunctivitis Charles P. Andrews, Paul H. Ratner, Benjamin Ehler, Edward G. Brooks, Bradley H Pollock, Dan A. Ramirez, Robert L. Jacobs Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen. Robert L. Jacobs, Daniel A. Ramirez, Charles P. Andrews Fluticasone furoate nasal spray is more effective than fexofenadine for nighttime symptoms of seasonal allergy. Bruce G Martin, Robert L. Jacobs, Dale Mohar, Joseph D Diaz, Niran J. Amar, Harold B. Kaiser, Mark Vandewalker, Jonathan A. Bernstein, William T Toler, Barbara A. Prillaman, Anand A. Dalal, Laurie A. Lee, Edward E. Philpot, Charles P. Andrews Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: A placebo-controlled trial Donald P. Tashkin, Michael R. Littner, Charles P. Andrews, Latanya Tomlinson, Mike Rinehart, Kimberly Denis-Mize Optimal dose selection of fluticasone furoate nasal spray for the treatment of seasonal allergic rhinitis in adults and adolescents. Bruce G. Martin, Paul H. Ratner, Frank C. Hampel, Charles P. Andrews, T. Toler, Wei Wu, Melissa A. Faris, Edward E. Philpot Comparison of fluticasone propionate aqueous nasal spray and oral montelukast for the treatment of seasonal allergic rhinitis symptoms. Bruce G. Martin, Charles P. Andrews, Julius van Bavel, Frank C. Hampel, Kristofer C. Klein, Barbara A. Prillaman, Melissa A. Faris, Edward E. Philpot Hypersensitivity pneumonitis: beyond classic occupational disease–changing concepts of diagnosis and management Robert L. Jacobs, Charles P. Andrews, Jacqueline J. Coalson Comparative Efficacies and Tolerabilities of Intravenous Azithromycin Plus Ceftriaxone and Intravenous Levofloxacin with Step-Down Oral Therapy for Hospitalized Patients with Moderate to Severe Community-Acquired Pneumonia Marcus J. Zervos, Lionel A. Mandell, Peter S. Vrooman, Charles P. Andrews, Andrew McIvor, Ramzan H. Abdulla, Pascal J. de Caprariis, Charles Knirsch, Guy W. Amsden, Michael S. Niederman, Hartmut Lode Hypersensitivity pneumonia-nonspecific interstitial pneumonia/fibrosis histopathologic presentation: a study in diagnosis and long-term management. Robert L. Jacobs, Charles P. Andrews Organic antigen-induced interstitial lung disease: diagnosis and management Robert L. Jacobs, Charles P. Andrews, Jacqueline J. Coalson Acute pulmonary edema associated with use of low-molecular weight dextran for prevention of microvascular thrombosis. Kurt J. Kitziger, William E. Sanders, Charles P. Andrews Clinical Determinants of Abnormalities in Pulmonary Functions in Survivors of the Adult Respiratory Distress Syndrome Jay I. Peters, Randall C. Bell, Thomas J. Prihoda, Gary J. Harris, Charles P. Andrews, Waldemar G. Johanson Hypersensitivity Pneumonitis Treated with an Electrostatic Dust Filter Robert L. Jacobs, Charles P. Andrews, Frank O. Jacobs Aspergillus antigen detection in bronchoalveolar lavage fluid from patients with invasive aspergillosis and aspergillomas Charles P. Andrews, Marc H Weiner Diagnosis of Nosocomial Bacterial Pneumonia in Acute, Diffuse Lung Injury Charles P. Andrews, Jacqueline J. Coalson, Jan D. Smith, Waldemar G. Johanson Immunodiagnosis of invasive pulmonary aspergillosis in rabbits. Fungal antigen detected by radioimmunoassay in bronchoalveolar lavage fluid. Charles P. Andrews, Marc H Weiner

Contact Charles Porter Andrews, M.d., P.a.

Frequently Asked Questions

Can I book online with Charles Porter Andrews, M.d., P.a. as a new patient?

Yes, Charles Porter Andrews, M.d., P.a. has at least one appointment type (such as walk-in or flu shot) that allows new patients to book online.

Does Charles Porter Andrews, M.d., P.a. offer telehealth or virtual appointments?

Yes, Charles Porter Andrews, M.d., P.a. offers telehealth services for virtual appointments.

i About this listing

This page is part of a directory of medical practices. Cortico invests in keeping this information as up-to-date as possible, and encourages practices to manage their listings.

The directory listing is used for:

  • Improving patient access to care.
  • Helping patients and providers find a link to the official practice website.
  • Improving admin efficiency by allowing providers/staff to find Fax numbers and related office info.
  • Helping practices connect with local providers looking for jobs.